Ticker

Analyst Price Targets — XTNT

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
October 18, 2024 8:58 amChase KnickerbockerCraig-Hallum$1.50$0.56StreetInsider Xtant Medical (XTNT) PT Lowered to $1.50 at Craig-Hallum

Latest News for XTNT

Xtant Medical Finalizes Companion Spine Transactions

Xtant received $10.7 million in satisfaction of unsecured promissory note issued to Xtant by Companion Spine plus related working capital adjustments BELGRADE, Mont., March 2, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it has received $10.7 million from Companion…

PRNewsWire • Mar 2, 2026
Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference

BELGRADE, Mont., Feb. 25, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, today announced that Sean Browne, CEO, Scott Neils, CFO, and Mark Schallenberger, COO, will be participating in the Canaccord Genuity 2026 Musculoskeletal Conference, which is being held…

PRNewsWire • Feb 25, 2026
AWM Investment Company Inc. Takes $4.88 Million Position in Xtant Medical Holdings, Inc. $XTNT

AWM Investment Company Inc. purchased a new stake in shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,596,621 shares of the medical device company's stock, valued at approximately $4,875,000. AWM Investment Company

Defense World • Dec 13, 2025
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft

nanOss Strata™ is designed to more closely mimic the structure of human bone, increase the graft's surface area, improve osteoconductivity and enhance the stimulation of cellular activity BELGRADE, Mont. , Dec. 11, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced the…

PRNewsWire • Dec 11, 2025

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for XTNT.

No House trades found for XTNT.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top